Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation

National Medical Journal of China

Volumn 85, Issue 35, 2005, Pages 2497-2502

  Zhao, Jie ^a   Zhao, Xiang Yu ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Bone marrow transplantation; Graft vs host disease; Granulocyte colony stimulating factor; Interleukin 11

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY; PHOSPHATE BUFFERED SALINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 11; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL SUSPENSION; CHIMERA; CONTROLLED STUDY; DEATH; DONOR; DRUG DOSE REGIMEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INCIDENCE; INTESTINE; LETHAL DOSE; LETHALITY; LIVER; MICROSCOPY; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOLOGY; RECIPIENT; SKIN; SPLEEN; SPLEEN CELL; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SYMPTOMATOLOGY; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-11; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT PROTEINS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 25844505021     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cavazzana-Calvo M, André-Schmzotz I, Hacein-Bey-Abina S, et al. Improving immune reconstruction while preventing graft-versus-host disease in allogeneic stem cell transplantation. Semi Hematol,2002, 39:32-40.
2. Aversa F, Tabilio A, Velaridi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplocyte. N Engl J Med, 1998, 339: 1186-1193.
3. Chang YJ, Zhao XY, Huang XJ. Effect of in vivo rhG-CSF on T cells of bone marrow and its mechanism. Natl Med J China, 2004, 84: 833-835.
4. Morton J, Hutchins C, Durrant S. Granulocyte colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood, 2001,98:3186-3191.
5. Curti A, Ratta M, Corinti S, et al. Interleukin-11 induces Th2 polarization of human CD4 ( + ) T cells. Blood, 2001, 97: 2758-2763.
6. Sudo Y, Shimazaki C, Ashihara E, et al, Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hamatopoietic stem cells and progenitor cells into blood in mice. Blood, 1997,89:3186-3191.
7. Hartung G,Zeis M, Glass B, et al. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyter colony-stimulating factor(G-CSF) and stem cell factor(SCF) in a murine translantatation model. Bone Marrow Transplant,2003,32:49-56.
8. Daniel HF, Kazuhiro K, Rhett S, et al. Donor CD4 enrihed cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Bood,1994,84:3540-3549.
9. Chen YH, Huang XJ, Xu LP, et al. A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for maliganant hematologic disease. Natl Med J China, 2002,82:1306-1309.
10. Huang XJ, Guo NS, Ren HY, et al. An improved anti-lenkemia effect achieved with donor progenitor cell transfusion for relapse patients after allogeneic bone marrow transplantation. Chin Med J, 2003,116:736-741.
11. Venkova K, Keith JC, Meerveld B. Oral treatment with recombinant human interleukin-11 improves mucosal transport in the colon of human leukocyte antigen-B27 transgenic rats. J Pharmacol Exp Ther, 2004, 308:206-213.
12. Hill GR, Kenneth R, Cooke KR, et al. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. Clin Invest, 1998, 102: 115-123.
13. Meng FY, Jiang ZJ, Yi ZS, et al, Study of murine hematopoietic stem/progenitor cell mobilized by recombinant human interleukinll combination with granulocyte colony stimulating factor. Chin J Hematol,2003,24:225-227.
14. Ferrara JL, Cooke KP, Pan L, et al. The immunopatho-physiology of acute graft-versus-host-disease. Stem Cells, 1996,4:473-489.